Experimental models confirm that CLL cells with combined TP53/CDKN2A inactivation proliferative autonomously upon BCR stimulation and that this proliferation remains strictly BCR-dependent. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.